GO:0045540 regulation of cholesterol biosynthetic process: Metabolic Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045540 describes any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
• Cholesterol biosynthesis is a highly regulated metabolic pathway that converts acetyl-CoA into cholesterol through the mevalonate pathway, and its dysregulation is linked to cardiovascular, metabolic, and neurodegenerative diseases.
• Key transcription factors such as SREBP-2 and nuclear receptors like LXR and FXR coordinate the expression of genes encoding cholesterol biosynthetic enzymes.
• Beyond transcription, cholesterol biosynthesis is controlled by post-translational mechanisms including AMPK-mediated phosphorylation and feedback inhibition by sterols.
• Altered regulation of cholesterol biosynthesis contributes to macrophage foam cell formation, osteoarthritis, and cancer progression.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential tools to dissect causal roles of regulatory genes in cholesterol biosynthesis.
Description
Cholesterol is an essential lipid that maintains membrane fluidity, serves as a precursor for steroid hormones, bile acids, and vitamin D, and plays critical roles in cell signaling. The biosynthetic pathway that produces cholesterol from acetyl-CoA is one of the most energetically expensive anabolic processes in mammalian cells, and its activity must be precisely tuned to meet cellular demands while avoiding lipotoxicity. The Gene Ontology term GO:0045540, regulation of cholesterol biosynthetic process, encompasses all molecular events that modulate the rate, frequency, or extent of this pathway. Understanding this regulatory network is fundamental for researchers studying metabolic disorders, cardiovascular disease, cancer, and neurodegeneration. The regulation of cholesterol biosynthesis occurs at multiple levels, including transcriptional control by sterol regulatory element-binding proteins (SREBPs), feedback inhibition by sterols, hormonal signals such as thyroid hormone, and post-translational modifications of key enzymes. Dysregulation of these control mechanisms is a hallmark of diseases such as atherosclerosis, non-alcoholic fatty liver disease, and osteoarthritis. This article provides a comprehensive overview of GO:0045540, integrating authoritative QuickGO definitions with published literature to guide experimental design and therapeutic targeting.
regulation of cholesterol biosynthetic process At A Glance
| GO ID | GO:0045540 |
|---|---|
| GO term | regulation of cholesterol biosynthetic process |
| Ontology | biological_process |
| Synonym | regulation of cholesterol anabolism; regulation of cholesterol biosynthesis; regulation of cholesterol formation; regulation of cholesterol synthesis |
| Major function | Modulates the rate of cholesterol production from acetyl-CoA, maintaining lipid homeostasis |
| Key regulators | SREBP-2, HMGCR, LXR, FXR, AMPK, INSIG1/2 |
| Associated pathways | Mevalonate pathway, bile acid synthesis, steroidogenesis |
| Disease relevance | Atherosclerosis, metabolic syndrome, osteoarthritis, cancer |
What Is GO:0045540?
GO:0045540, regulation of cholesterol biosynthetic process, is defined as any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. In other words, it includes all mechanisms that control how much cholesterol a cell produces, from transcriptional regulation of biosynthetic enzymes to feedback inhibition by the end product. This term is a biological process and is distinct from the biosynthetic process itself (GO:0006695), focusing instead on the regulatory inputs that adjust pathway activity.
Why Is regulation of cholesterol biosynthetic process Important in Cell Biology?
The regulation of cholesterol biosynthesis is critical for cellular and systemic lipid homeostasis, and its dysfunction underlies some of the most prevalent human diseases, including cardiovascular disease, type 2 diabetes, and neurodegenerative disorders. Because cholesterol is essential for membrane integrity and signaling, cells have evolved layered regulatory mechanisms that sense sterol levels and adjust enzyme expression accordingly. Pharmacological targeting of this pathway, such as with statins, has proven to be one of the most successful therapeutic strategies in modern medicine, underscoring the importance of understanding its regulation.
• Maintains membrane fluidity and permeability by adjusting cholesterol supply.
• Prevents toxic accumulation of sterol intermediates that can damage cells.
• Controls production of bile acids and steroid hormones.
• Dysregulation leads to hypercholesterolemia and atherosclerosis.
• Altered cholesterol biosynthesis supports cancer cell proliferation.
• Implicated in osteoarthritis through the CH25H-CYP7B1-RORα axis.
• Autophagy regulates lipid metabolism, including cholesterol biosynthesis.
• Thyroid hormone modulates cholesterol synthesis and clearance.
• Macrophage lipid metabolism is tightly linked to immune function.
• Provides targets for statins and other lipid-lowering drugs.
What Happens During regulation of cholesterol biosynthetic process?
Transcriptional control by SREBP-2
In simple terms: When cells need more cholesterol, a protein called SREBP-2 turns on the genes that make cholesterol.
Sterol regulatory element-binding protein 2 (SREBP-2) is the master transcription factor that activates genes encoding cholesterol biosynthetic enzymes, including HMGCR, MVK, and LDLR. When sterol levels drop, SREBP-2 is released from the endoplasmic reticulum and translocates to the nucleus to drive transcription of its target genes, thereby increasing cholesterol synthesis.
Feedback inhibition by sterols
In simple terms: Too much cholesterol shuts down its own production to prevent buildup.
Elevated levels of cholesterol and oxysterols inhibit the activity of HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway, through both transcriptional and post-translational mechanisms. Sterols promote the degradation of HMGCR and block SREBP-2 processing, providing a rapid negative feedback loop.
Hormonal regulation
In simple terms: Hormones like thyroid hormone can speed up or slow down cholesterol production.
Thyroid hormone regulates cholesterol metabolism by increasing the expression of LDL receptors and enhancing cholesterol clearance, while also affecting hepatic cholesterol synthesis. Other hormones, including insulin and glucagon, modulate the activity of key enzymes in the pathway.
Post-translational modification of enzymes
In simple terms: Enzymes that make cholesterol can be switched on or off by chemical tags.
AMP-activated protein kinase (AMPK) phosphorylates and inhibits HMGCR, reducing cholesterol synthesis when cellular energy is low. Additionally, the stability of HMGCR is controlled by the ubiquitin-proteasome system in response to sterol levels.
Cross-talk with bile acid and oxysterol signaling
In simple terms: Cholesterol breakdown products send signals that adjust how much cholesterol is made.
Bile acids activate the nuclear receptor FXR, which suppresses cholesterol 7α-hydroxylase (CYP7A1) and modulates cholesterol biosynthesis. Oxysterols such as 25-hydroxycholesterol activate LXR and also inhibit SREBP-2, linking cholesterol synthesis to inflammatory and immune responses.
Key Genes Involved in GO:0045540 regulation of cholesterol biosynthetic process
The following genes and proteins are central to the regulation of cholesterol biosynthetic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCR | Rate-limiting enzyme of mevalonate pathway; target of statins | Central to cholesterol synthesis and feedback regulation |
| SREBF2 | Transcription factor activating cholesterol biosynthetic genes | Master regulator of cholesterol homeostasis |
| INSIG1 | Retains SREBP-2 in ER and promotes HMGCR degradation | Key node in sterol sensing |
| INSIG2 | Similar to INSIG1, regulates SREBP processing | Modulates cholesterol synthesis |
| SCAP | Sterol-sensing escort protein for SREBP-2 | Controls SREBP-2 activation |
| LDLR | Mediates uptake of LDL cholesterol | Regulates plasma cholesterol levels |
| NR1H3 (LXRα) | Nuclear receptor activated by oxysterols; promotes cholesterol efflux | Links cholesterol metabolism to inflammation |
| NR1H4 (FXR) | Bile acid receptor; suppresses CYP7A1 | Regulates bile acid and cholesterol homeostasis |
| CYP7A1 | Rate-limiting enzyme in bile acid synthesis | Connects cholesterol catabolism to regulation |
| CH25H | Produces 25-hydroxycholesterol | Involved in osteoarthritis and immune regulation |
| CYP7B1 | Oxysterol 7α-hydroxylase | Part of CH25H-CYP7B1-RORα axis |
| RORA | Nuclear receptor regulating lipid metabolism | Linked to osteoarthritis and cholesterol regulation |
| PRKAA1 (AMPKα1) | Energy sensor; phosphorylates HMGCR | Inhibits cholesterol synthesis under low energy |
| PRKAA2 (AMPKα2) | Catalytic subunit of AMPK | Mediates metabolic regulation of cholesterol synthesis |
| SQLE | Squalene monooxygenase; second rate-limiting enzyme | Regulated by sterols and SREBP-2 |
| MVK | Mevalonate kinase | Biosynthetic enzyme regulated by SREBP-2 |
| FDFT1 | Squalene synthase | Catalyzes first committed step to sterols |
| DHCR7 | 7-dehydrocholesterol reductase | Final step of cholesterol synthesis; linked to Smith-Lemli-Opitz syndrome |
How Is regulation of cholesterol biosynthetic process Regulated?
The regulation of cholesterol biosynthetic process is orchestrated by a network of transcription factors, nuclear receptors, and signaling kinases. SREBP-2 is the primary transcriptional activator, while INSIG proteins and SCAP sense sterol levels to control SREBP-2 processing. Oxysterols activate LXR, which induces genes involved in cholesterol efflux and inhibits SREBP-2, providing a counter-regulatory mechanism. Bile acids activate FXR to suppress CYP7A1 and modulate cholesterol catabolism. AMPK phosphorylates HMGCR to inhibit its activity under energy stress. Additionally, thyroid hormone influences cholesterol synthesis and clearance through effects on gene expression. Autophagy also contributes to lipid metabolism by degrading lipid droplets and regulating cholesterol synthesis.
regulation of cholesterol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGCR | Hypercholesterolemia, atherosclerosis | Knockout or point mutation in HepG2 cells |
| SREBF2 | Metabolic syndrome, cancer | Overexpression and knockout in cancer cell lines |
| CH25H | Osteoarthritis | Knockout mouse chondrocytes |
| CYP7B1 | Osteoarthritis, bile acid disorders | Knock-in of patient mutations |
| INSIG1 | Lipid disorders | Knockout in hepatocytes |
Atherosclerosis and Cardiovascular Disease
Dysregulation of cholesterol biosynthesis leads to elevated plasma LDL cholesterol, a major risk factor for atherosclerosis. Statins, which inhibit HMGCR, are widely used to lower cholesterol and reduce cardiovascular events. Macrophage foam cell formation is driven by imbalanced cholesterol uptake and efflux, processes regulated by LXR and SREBP.
Osteoarthritis
The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis pathogenesis. 25-hydroxycholesterol produced by CH25H modulates inflammatory responses in joint tissues, and its dysregulation contributes to cartilage degradation.
Metabolic Syndrome and Fatty Liver Disease
Altered regulation of cholesterol biosynthesis is associated with insulin resistance, non-alcoholic fatty liver disease, and metabolic syndrome. AMPK activation improves lipid profiles by inhibiting cholesterol synthesis.
Cancer
Many cancer cells exhibit increased cholesterol synthesis to support rapid proliferation. Targeting SREBP-2 or HMGCR has been explored as an anti-cancer strategy, though effects are context-dependent.
From regulation of cholesterol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cholesterol synthesis? | CRISPR knockout in HepG2 or HeLa cells |
| Does a point mutation in HMGCR affect statin sensitivity? | Point mutation knock-in via CRISPR |
| Does overexpression of SREBP-2 increase cholesterol? | CRISPRa or lentiviral overexpression |
| Does a tag on HMGCR affect its localization? | Tagged knock-in (e.g., GFP) |
| Does CH25H mutation alter osteoarthritis progression? | Knockout mouse model |
| Does AMPK phosphorylation of HMGCR regulate activity? | Phospho-mutant knock-in |
How to Study the regulation of cholesterol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify SREBP-2 target genes |
| Lipidomics (LC-MS) | Cholesterol and sterol intermediates | Quantify pathway flux |
| ChIP-seq | SREBP-2 binding sites | Map transcriptional regulation |
| Western blot | Protein levels of HMGCR, SREBP-2 | Assess feedback regulation |
| Filipin staining | Free cholesterol distribution | Visualize cholesterol accumulation |
| Luciferase reporter | SREBP-2 transcriptional activity | Screen for regulators |
| CRISPR screen | Genes affecting cholesterol levels | Identify novel regulators |
Transcriptomic Analysis
RNA-seq can quantify expression of cholesterol biosynthetic genes and identify SREBP-2 target networks. Comparing wild-type and knockout cells reveals transcriptional changes in response to regulatory perturbations.
Lipidomics and Metabolomics
Mass spectrometry-based lipidomics measures cholesterol and intermediate sterols to assess pathway flux. Metabolomic profiling can detect mevalonate pathway intermediates.
Protein-Protein Interaction Studies
Co-immunoprecipitation and proximity ligation assays can map interactions between SREBP-2, SCAP, and INSIG proteins. These methods help define the sterol-sensing complex.
Imaging and Reporter Assays
Fluorescent cholesterol probes (e.g., filipin) and luciferase reporters driven by SREBP-2 response elements allow visualization and quantification of cholesterol synthesis in live cells.
How CRISPR Can Be Used to Study GO:0045540 regulation of cholesterol biosynthetic process
Knockout
CRISPR knockout of candidate regulatory genes (e.g., SREBF2, INSIG1) in cell lines such as HepG2 or HeLa can determine their necessity for cholesterol biosynthesis. Knockout models also help validate off-target effects of pharmacological inhibitors.
Point Mutation
Introducing specific point mutations (e.g., in HMGCR or AMPK phosphorylation sites) via CRISPR base editing or HDR allows precise interrogation of regulatory phosphorylation and sterol sensing.
Knock-in
Knock-in of tagged versions of HMGCR or SREBP-2 (e.g., GFP, HA) enables live-cell imaging and proteomic analysis of their dynamics under different sterol conditions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of SREBP-2 or constitutively active SREBP-2 can drive cholesterol synthesis and model hypercholesterolemia in vitro.
How EDITGENE Supports regulation of cholesterol biosynthetic process Research
Researchers studying regulation of cholesterol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in controlling pathway activity, and CRISPR-based models provide the most direct approach for such functional validation.
Contact EDITGENE today to design your custom CRISPR model for regulation of cholesterol biosynthetic process research.
Frequently Asked Questions About regulation of cholesterol biosynthetic process
What is GO:0045540?
GO:0045540 is the Gene Ontology term for regulation of cholesterol biosynthetic process, defined as any process that modulates the frequency, rate or extent of cholesterol formation.
What genes are involved in regulation of cholesterol biosynthetic process?
Key genes include HMGCR, SREBF2, INSIG1, INSIG2, SCAP, LDLR, NR1H3, NR1H4, CYP7A1, CH25H, CYP7B1, RORA, PRKAA1, PRKAA2, SQLE, MVK, FDFT1, and DHCR7.
How is cholesterol biosynthesis regulated?
It is regulated by transcription factors like SREBP-2, feedback inhibition by sterols, hormonal signals such as thyroid hormone, and post-translational modifications by AMPK.
What diseases are linked to dysregulation of cholesterol biosynthesis?
Atherosclerosis, metabolic syndrome, osteoarthritis, fatty liver disease, and cancer are associated with altered regulation of cholesterol biosynthesis.
What is the role of SREBP-2 in cholesterol biosynthesis?
SREBP-2 is the master transcription factor that activates genes encoding cholesterol biosynthetic enzymes in response to low sterol levels.
How does AMPK regulate cholesterol synthesis?
AMPK phosphorylates and inhibits HMGCR, reducing cholesterol synthesis when cellular energy is low.
What is the CH25H-CYP7B1-RORα axis?
It is a metabolic pathway involving 25-hydroxycholesterol and its derivatives that regulates osteoarthritis pathogenesis.
Can CRISPR be used to study cholesterol biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in cholesterol regulation.
What are the synonyms for GO:0045540?
Synonyms include regulation of cholesterol anabolism, regulation of cholesterol biosynthesis, regulation of cholesterol formation, and regulation of cholesterol synthesis.
Why is regulation of cholesterol biosynthesis important for drug discovery?
It is the target of statins and other lipid-lowering drugs, and understanding its regulation can lead to new therapies for cardiovascular and metabolic diseases.
Conclusion
The regulation of cholesterol biosynthetic process (GO:0045540) is a fundamental biological process that integrates transcriptional, post-translational, and hormonal signals to maintain lipid homeostasis. Its dysregulation is central to prevalent human diseases, making it a prime target for therapeutic intervention. CRISPR-based functional genomics, combined with lipidomics and transcriptomics, offers powerful tools to uncover new regulatory mechanisms and validate drug targets. Continued research into this pathway promises to yield novel strategies for managing cardiovascular, metabolic, and inflammatory diseases.
References
- 1. Mullur R et al.. 2014. Thyroid hormone regulation of metabolism.. Physiol Rev 94(2):355-82 PMID: 24692351
- 2. Yan J et al.. 2020. Lipid Metabolism in Regulation of Macrophage Functions.. Trends Cell Biol 30(12):979-989 PMID: 33036870
- 3. Chen L et al.. 2019. Regulation of glucose and lipid metabolism in health and disease.. Sci China Life Sci 62(11):1420-1458 PMID: 31686320
- 4. Schade DS et al.. 2020. Cholesterol Review: A Metabolically Important Molecule.. Endocr Pract 26(12):1514-1523 PMID: 33471744
- 5. Chiang JY. 2013. Bile acid metabolism and signaling.. Compr Physiol 3(3):1191-212 PMID: 23897684
- 6. Parente M et al.. 2023. Regulation of cholesterol metabolism: New players for an old physiological process.. J Cell Biochem 124(10):1449-1465 PMID: 37796135
- 7. Choi WS et al.. 2019. The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis.. Nature 566(7743):254-258 PMID: 30728500
- 8. Singh R et al.. 2009. Autophagy regulates lipid metabolism.. Nature 458(7242):1131-5 PMID: 19339967
